The Filing Desk

ICON vs IQVIA

ICON ICLR · IQVIA IQV · Life Sciences Tools & Services

IQVIA reported revenue of $16.3 billion in fiscal 2025, 2.0 times ICON's $8.3 billion in fiscal 2025. ICON's revenue grew 0.8% in its latest year, and IQVIA's grew 5.9%. ICON had an operating margin of 5.4%, against 13.4% at IQVIA. Free cash flow was $862 million at ICON and $2.1 billion at IQVIA.

Side by side

ICONIQVIA
Latest fiscal yearFY2025, Dec 31, 2025FY2025, Dec 31, 2025
Revenue$8.3B$16.3B
Revenue growth0.8%5.9%
Revenue growth a year, last 5 years24.2%7.5%
Gross margin——
Operating margin5.4%13.4%
Net margin2.8%8.3%
Free cash flow$862M$2.1B
Free cash flow margin10.4%12.6%
Return on capital3.4%9.4%
Net debt to EBITDA2.7x4.2x
Dividends and buybacks$750M$1.2B
Change in diluted share count−4.9%−5.4%
Last close$190.36$250.55
P/E at the last close—30.5×
Insider trades, last 12 monthssold $3.6 millionsold $39.3 million
Piotroski F-score6 of 85 of 8
Amounts in each company's own currency, US$ unless marked (a foreign company may report in another), each company's latest fiscal year from its 10-K, or 20-F or 40-F for a foreign company. Growth rates compare with the year before; the five-year rate is the average a year. Free cash flow is cash from operations minus capital spending; return on capital is after-tax operating income over the money invested in the business; P/E is the last close over the latest earnings per share. Banks are measured differently (return on equity, efficiency ratio), so some rows apply to one company only.

Ten years

Revenue
US$ billions, fiscal years
ICONIQVIA
Operating margin
Percent of revenue
ICONIQVIA
Free cash flow
US$ billions. Cash from operations minus capital expenditure.
ICONIQVIA

Start a new comparison

Source: the companies' Form 10-K filings, from SEC EDGAR, and the last close. For information only, not investment advice: the figures describe results, not which company is the better investment. The Filing Desk is not affiliated with either company. Full figures on the ICON and IQVIA pages.